Solid tumors Trials in Detroit, United States
Conditions / Solid tumors / Detroit, United States
Solid tumors has been the subject of sustained clinical investigation across multiple research sites.
55 total trials for this combination
Showing top 10 of 55 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00940225 | Study of Cabozantinib (XL184) in Adults With Advanced Malignancies | COMPLETED | PHASE2 |
| NCT01231347 | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | COMPLETED | PHASE3 |
| NCT02903914 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | COMPLETED | PHASE1 |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT02500199 | Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors | UNKNOWN | PHASE1 |
| NCT04589845 | Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study | RECRUITING | PHASE2 |
| NCT02517398 | MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT03486873 | Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) | RECRUITING | — |
| NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma | RECRUITING | — |